The ongoing Ebola outbreak has now become the most rapidly spreading in history, resulting in over 750 deaths. In Eastern Congo, there have been more than 2,000 confirmed cases, with additional suspected cases emerging in two other provinces, including near Kisangani, a major city in the country. This has heightened concerns about the extent of the virus’s reach.
Health officials have reported that 80% of new cases are linked to unknown transmission chains, making it challenging to track and contain the spread of the virus. The specific origin of the outbreak remains unidentified. The virus strain responsible for this outbreak, Bundibugyo Ebola, does not currently have approved vaccines or treatments, posing a significant challenge for containment efforts.
The escalating outbreak has put immense strain on the region’s already fragile healthcare system. Recent strikes by unpaid staff at key health centers have further hampered response efforts. Workers at treatment facilities demanded payment for their hazardous work, leading to temporary closures and disruptions in fighting the outbreak.
The outbreak has spread in a region already struggling with limited infrastructure, conflict, and misinformation about Ebola. The disease spreads from infected animals to humans and then between individuals through direct contact with bodily fluids. Symptoms include fever, vomiting, diarrhea, muscle pain, and in severe cases, internal and external bleeding.
To combat the outbreak, researchers have initiated trials for potential treatments targeting the Bundibugyo virus strain. These treatments include Gilead Sciences’ remdesivir and Mapp Biopharmaceutical’s experimental MBP134. The study aims to determine the effectiveness of these treatments but may take several months and involve a large number of participants before conclusive results are obtained.
Authorities have also imposed restrictions on traditional funeral practices to prevent further spread of the virus after death. While these measures have faced resistance from some local communities, they are crucial in containing the outbreak. Researchers are hopeful that ongoing trials will provide valuable insights into combating the Ebola virus.